Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology

By Danica A Helb, Martin Jones, Elizabeth Story, C. Boehme, E. Wallace, K. Ho, J. Kop, Michelle R. Owens, R. Rodgers, P. Banada and 15 more. Journal of Clinical Microbiology, 2009

1,054 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/290ce7843cd3334a42e15583935bac4d66263e88

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Madhukar Pai
2. S. Chakravorty
3. D. Alland

In Infectious Diseases

1. Madhukar Pai
2. D. Persing

In Surgery

1. Madhukar Pai

Citations in the corpus

• Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017, background): “These assays are promising, but are not yet commercially available [146, 159, 160].”
• Detection (2020, neutral): “An RTP flow is determined by a tuple composed of ( IP src , IP dst , Port src , Port dst , SSRC , Type payload ).”
• The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing (2017, methodology): “tuberculosis directly from sputum, with a limit of detection (LOD) of 131 CFU/ml (1).”